For example, we recently showed that elevated expression of CDKN1a (p21) confers chemoresistance to renal cell carcinomas, which share common hypoxia-induced, pro-angiogenic signatures with vascular tumors [53]. The gene discussed is CDKN1A; the disease is hereditary clear cell renal cell carcinoma.